Low-intensity versus medium-intensity continuous renal replacement therapy for critically ill patients (LIMIT) trial: Protocol summary and statistical analysis plan of a randomised clinical trial
Background Severe acute kidney injury in critically ill patients may require continuous renal replacement therapy (CRRT), yet mortality remains high. A standard CRRT intensity is 20–25 mL/kg/hr, because higher doses have not improved outcomes. Excessive treatment may cause harm by removing antibiotics and other essential substances and potentially impairing renal recovery. Observational data suggest that lower-intensity CRRT may be effective, warranting a clinical trial to compare low-versus standard-intensity therapy. Objective The objective of this study was to describe the prespecified protocol and the statistical analysis plan of the low-intensity versus medium-intensity continuous renal replacement therapy for critically Ill patients (LIMIT) trial. Design, Setting, Participants, and Interventions The LIMIT trial is an investigator-initiated, multicentre, open-label, randomised clinical trial, with a target sample size of 400 participants. The trial compares low-intensity CRRT (12 mL/kg/hr) and medium-intensity CRRT (25 mL/kg/hr) in adult patients with acute kidney injury requiring CRRT in the participating intensive care units. Main outcome measures The primary outcome is a hierarchical composite of survival and time to successful liberation from RRT through day 28 from randomisation, analysed using a win-ratio. Secondary outcomes include intensive care unit mortality, hospital mortality, dialysis dependence at hospital discharge among survivors, vasopressor-free days at day 28, and ventilator-free days at day 28. Conclusion The LIMIT trial will evaluate the effect of low-intensity CRRT on mortality and time to successful liberation from RRT compared with medium-intensity CRRT in adults with acute kidney injury. Its findings may also inform future research on broader patient-centred and societal implications of CRRT intensity.
Authors
- Ryo Yamamoto (ORCID: https://orcid.org/0000-0001-8772-9600)
- Aiko Tanaka (ORCID: https://orcid.org/0000-0002-8990-1336)
- Amemiya Yu
- Kyohei Miyamoto (ORCID: https://orcid.org/0000-0001-5473-2731)
- Yu Kawazoe (ORCID: https://orcid.org/0000-0003-4471-4788)
- Akira Endo (ORCID: https://orcid.org/0000-0002-5967-0776)
- Shiro Tanaka (ORCID: https://orcid.org/0000-0001-6817-5235)
- Hiraaki Okuzawa (ORCID: https://orcid.org/0009-0009-6367-7688)
- Naoya Iguchi (ORCID: https://orcid.org/0000-0002-4194-6826)
- Tomoko Fujii (ORCID: https://orcid.org/0000-0003-3854-4081)
- Hisashi Imahase
- Megumi Furukawa
- Makoto Chida
Institutions
- Jikei University School of Medicine (JP)
- Kansai Medical University (JP)
- Kyushu University (JP)
- Jichi Medical University (JP)
- Wakayama Medical University (JP)
- Keio University (JP)
- Osaka Medical and Pharmaceutical University (JP)
- Hokkaido University (JP)
- Tsuchiura Kyodo General Hospital (JP)
- Tohoku University Hospital (JP)
- Kyushu University Hospital (JP)
- Keio University Hospital (JP)
- The Jikei University Hospital (JP)
- Sendai Medical Center (JP)
- Monash University (AU)
- Wakayama University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Critical Care and Resuscitation
- Published
- 2026-09-29
- DOI
- https://doi.org/10.1016/j.ccrj.2026.100223
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00